nodes	percent_of_prediction	percent_of_DWPC	metapath
Mercaptopurine—PPAT—Fluorouracil—urinary bladder cancer	0.152	0.208	CbGbCtD
Mercaptopurine—SLC29A2—Gemcitabine—urinary bladder cancer	0.118	0.162	CbGbCtD
Mercaptopurine—SLC28A3—Gemcitabine—urinary bladder cancer	0.102	0.14	CbGbCtD
Mercaptopurine—SLC29A1—Gemcitabine—urinary bladder cancer	0.0677	0.0928	CbGbCtD
Mercaptopurine—SLC29A1—Fluorouracil—urinary bladder cancer	0.0579	0.0794	CbGbCtD
Mercaptopurine—ABCC5—Fluorouracil—urinary bladder cancer	0.0442	0.0606	CbGbCtD
Mercaptopurine—ABCC5—Cisplatin—urinary bladder cancer	0.0376	0.0515	CbGbCtD
Mercaptopurine—XDH—Carboplatin—urinary bladder cancer	0.036	0.0493	CbGbCtD
Mercaptopurine—XDH—Cisplatin—urinary bladder cancer	0.0307	0.0421	CbGbCtD
Mercaptopurine—AOX1—Methotrexate—urinary bladder cancer	0.0231	0.0316	CbGbCtD
Mercaptopurine—ABCC4—Fluorouracil—urinary bladder cancer	0.0213	0.0291	CbGbCtD
Mercaptopurine—XDH—Doxorubicin—urinary bladder cancer	0.0206	0.0282	CbGbCtD
Mercaptopurine—ABCC4—Methotrexate—urinary bladder cancer	0.0117	0.0161	CbGbCtD
Mercaptopurine—SLC22A8—Methotrexate—urinary bladder cancer	0.00732	0.01	CbGbCtD
Mercaptopurine—SLC28A2—renal system—urinary bladder cancer	0.00722	0.106	CbGeAlD
Mercaptopurine—SLC28A3—prostate gland—urinary bladder cancer	0.00297	0.0435	CbGeAlD
Mercaptopurine—SLC22A8—urine—urinary bladder cancer	0.00281	0.0412	CbGeAlD
Mercaptopurine—SLC29A2—prostate gland—urinary bladder cancer	0.00272	0.0398	CbGeAlD
Mercaptopurine—PPAT—prostate gland—urinary bladder cancer	0.00262	0.0383	CbGeAlD
Mercaptopurine—PPAT—seminal vesicle—urinary bladder cancer	0.00221	0.0324	CbGeAlD
Mercaptopurine—HPRT1—prostate gland—urinary bladder cancer	0.00201	0.0294	CbGeAlD
Mercaptopurine—XDH—prostate gland—urinary bladder cancer	0.00198	0.0291	CbGeAlD
Mercaptopurine—HPRT1—seminal vesicle—urinary bladder cancer	0.0017	0.0249	CbGeAlD
Mercaptopurine—TPMT—prostate gland—urinary bladder cancer	0.00169	0.0248	CbGeAlD
Mercaptopurine—SLC29A2—female reproductive system—urinary bladder cancer	0.00148	0.0217	CbGeAlD
Mercaptopurine—ABCC5—prostate gland—urinary bladder cancer	0.00147	0.0215	CbGeAlD
Mercaptopurine—TPMT—seminal vesicle—urinary bladder cancer	0.00143	0.021	CbGeAlD
Mercaptopurine—PPAT—female reproductive system—urinary bladder cancer	0.00143	0.0209	CbGeAlD
Mercaptopurine—HPRT1—smooth muscle tissue—urinary bladder cancer	0.00142	0.0208	CbGeAlD
Mercaptopurine—HPRT1—renal system—urinary bladder cancer	0.00137	0.02	CbGeAlD
Mercaptopurine—XDH—renal system—urinary bladder cancer	0.00135	0.0198	CbGeAlD
Mercaptopurine—SLC29A1—prostate gland—urinary bladder cancer	0.00135	0.0197	CbGeAlD
Mercaptopurine—HPRT1—urethra—urinary bladder cancer	0.00134	0.0197	CbGeAlD
Mercaptopurine—SLC29A2—vagina—urinary bladder cancer	0.00134	0.0197	CbGeAlD
Mercaptopurine—PPAT—vagina—urinary bladder cancer	0.00129	0.0189	CbGeAlD
Mercaptopurine—AOX1—prostate gland—urinary bladder cancer	0.00126	0.0185	CbGeAlD
Mercaptopurine—TPMT—renal system—urinary bladder cancer	0.00115	0.0169	CbGeAlD
Mercaptopurine—TPMT—urethra—urinary bladder cancer	0.00113	0.0166	CbGeAlD
Mercaptopurine—HPRT1—female reproductive system—urinary bladder cancer	0.0011	0.0161	CbGeAlD
Mercaptopurine—XDH—female reproductive system—urinary bladder cancer	0.00108	0.0159	CbGeAlD
Mercaptopurine—AOX1—seminal vesicle—urinary bladder cancer	0.00107	0.0156	CbGeAlD
Mercaptopurine—ABCC4—prostate gland—urinary bladder cancer	0.00102	0.0149	CbGeAlD
Mercaptopurine—SLC22A8—prostate gland—urinary bladder cancer	0.00101	0.0148	CbGeAlD
Mercaptopurine—HPRT1—vagina—urinary bladder cancer	0.000991	0.0145	CbGeAlD
Mercaptopurine—XDH—vagina—urinary bladder cancer	0.000978	0.0143	CbGeAlD
Mercaptopurine—SLC29A1—renal system—urinary bladder cancer	0.000918	0.0135	CbGeAlD
Mercaptopurine—SLC29A1—urethra—urinary bladder cancer	0.000902	0.0132	CbGeAlD
Mercaptopurine—SLC29A2—lymph node—urinary bladder cancer	0.000868	0.0127	CbGeAlD
Mercaptopurine—AOX1—renal system—urinary bladder cancer	0.000858	0.0126	CbGeAlD
Mercaptopurine—AOX1—urethra—urinary bladder cancer	0.000843	0.0124	CbGeAlD
Mercaptopurine—TPMT—vagina—urinary bladder cancer	0.000835	0.0122	CbGeAlD
Mercaptopurine—PPAT—lymph node—urinary bladder cancer	0.000835	0.0122	CbGeAlD
Mercaptopurine—SLC29A1—female reproductive system—urinary bladder cancer	0.000735	0.0108	CbGeAlD
Mercaptopurine—ABCC5—vagina—urinary bladder cancer	0.000724	0.0106	CbGeAlD
Mercaptopurine—ABCC4—renal system—urinary bladder cancer	0.000693	0.0102	CbGeAlD
Mercaptopurine—SLC22A8—renal system—urinary bladder cancer	0.000688	0.0101	CbGeAlD
Mercaptopurine—AOX1—female reproductive system—urinary bladder cancer	0.000688	0.0101	CbGeAlD
Mercaptopurine—SLC29A1—vagina—urinary bladder cancer	0.000665	0.00975	CbGeAlD
Mercaptopurine—HPRT1—lymph node—urinary bladder cancer	0.000641	0.00939	CbGeAlD
Mercaptopurine—AOX1—vagina—urinary bladder cancer	0.000622	0.00912	CbGeAlD
Mercaptopurine—ABCC4—female reproductive system—urinary bladder cancer	0.000555	0.00814	CbGeAlD
Mercaptopurine—TPMT—lymph node—urinary bladder cancer	0.00054	0.00792	CbGeAlD
Mercaptopurine—Hepatocellular injury—Cisplatin—urinary bladder cancer	0.000504	0.00409	CcSEcCtD
Mercaptopurine—Leukopenia—Mitomycin—urinary bladder cancer	0.000501	0.00406	CcSEcCtD
Mercaptopurine—Hyperuricaemia—Etoposide—urinary bladder cancer	0.000498	0.00404	CcSEcCtD
Mercaptopurine—Ulcer—Etoposide—urinary bladder cancer	0.000489	0.00396	CcSEcCtD
Mercaptopurine—Body temperature increased—Carboplatin—urinary bladder cancer	0.000485	0.00393	CcSEcCtD
Mercaptopurine—Blood uric acid increased—Etoposide—urinary bladder cancer	0.000471	0.00382	CcSEcCtD
Mercaptopurine—Sepsis—Gemcitabine—urinary bladder cancer	0.00047	0.00381	CcSEcCtD
Mercaptopurine—ABCC5—lymph node—urinary bladder cancer	0.000468	0.00687	CbGeAlD
Mercaptopurine—Skin hyperpigmentation—Methotrexate—urinary bladder cancer	0.000465	0.00377	CcSEcCtD
Mercaptopurine—Sepsis—Fluorouracil—urinary bladder cancer	0.000462	0.00374	CcSEcCtD
Mercaptopurine—Oedema—Mitomycin—urinary bladder cancer	0.000456	0.0037	CcSEcCtD
Mercaptopurine—Polyp—Methotrexate—urinary bladder cancer	0.000455	0.00369	CcSEcCtD
Mercaptopurine—Diarrhoea—Valrubicin—urinary bladder cancer	0.000453	0.00367	CcSEcCtD
Mercaptopurine—Thrombocytopenia—Mitomycin—urinary bladder cancer	0.000447	0.00362	CcSEcCtD
Mercaptopurine—Candida infection—Etoposide—urinary bladder cancer	0.000441	0.00358	CcSEcCtD
Mercaptopurine—Skin hyperpigmentation—Epirubicin—urinary bladder cancer	0.000435	0.00353	CcSEcCtD
Mercaptopurine—Anorexia—Mitomycin—urinary bladder cancer	0.000435	0.00353	CcSEcCtD
Mercaptopurine—SLC29A1—lymph node—urinary bladder cancer	0.00043	0.00631	CbGeAlD
Mercaptopurine—Polyp—Epirubicin—urinary bladder cancer	0.000426	0.00345	CcSEcCtD
Mercaptopurine—Vomiting—Valrubicin—urinary bladder cancer	0.000421	0.00341	CcSEcCtD
Mercaptopurine—Mouth ulceration—Etoposide—urinary bladder cancer	0.000418	0.00339	CcSEcCtD
Mercaptopurine—Rash—Valrubicin—urinary bladder cancer	0.000418	0.00339	CcSEcCtD
Mercaptopurine—Dermatitis—Valrubicin—urinary bladder cancer	0.000417	0.00338	CcSEcCtD
Mercaptopurine—Cyst—Methotrexate—urinary bladder cancer	0.000414	0.00336	CcSEcCtD
Mercaptopurine—Bone marrow depression—Methotrexate—urinary bladder cancer	0.00041	0.00332	CcSEcCtD
Mercaptopurine—Oral candidiasis—Epirubicin—urinary bladder cancer	0.000408	0.00331	CcSEcCtD
Mercaptopurine—Skin hyperpigmentation—Doxorubicin—urinary bladder cancer	0.000403	0.00327	CcSEcCtD
Mercaptopurine—AOX1—lymph node—urinary bladder cancer	0.000402	0.0059	CbGeAlD
Mercaptopurine—Sepsis—Etoposide—urinary bladder cancer	0.000401	0.00325	CcSEcCtD
Mercaptopurine—Decreased appetite—Mitomycin—urinary bladder cancer	0.000397	0.00322	CcSEcCtD
Mercaptopurine—Polyp—Doxorubicin—urinary bladder cancer	0.000394	0.00319	CcSEcCtD
Mercaptopurine—Nausea—Valrubicin—urinary bladder cancer	0.000393	0.00319	CcSEcCtD
Mercaptopurine—Cyst—Epirubicin—urinary bladder cancer	0.000387	0.00314	CcSEcCtD
Mercaptopurine—Bone marrow depression—Epirubicin—urinary bladder cancer	0.000384	0.00311	CcSEcCtD
Mercaptopurine—Pancytopenia—Thiotepa—urinary bladder cancer	0.000383	0.00311	CcSEcCtD
Mercaptopurine—Oral candidiasis—Doxorubicin—urinary bladder cancer	0.000377	0.00306	CcSEcCtD
Mercaptopurine—Body temperature increased—Mitomycin—urinary bladder cancer	0.000361	0.00292	CcSEcCtD
Mercaptopurine—Cyst—Doxorubicin—urinary bladder cancer	0.000359	0.00291	CcSEcCtD
Mercaptopurine—Hepatotoxicity—Methotrexate—urinary bladder cancer	0.000358	0.00291	CcSEcCtD
Mercaptopurine—Bone marrow depression—Doxorubicin—urinary bladder cancer	0.000355	0.00288	CcSEcCtD
Mercaptopurine—Stomatitis—Thiotepa—urinary bladder cancer	0.000351	0.00284	CcSEcCtD
Mercaptopurine—Hepatobiliary disease—Thiotepa—urinary bladder cancer	0.00034	0.00276	CcSEcCtD
Mercaptopurine—Breast disorder—Cisplatin—urinary bladder cancer	0.000331	0.00268	CcSEcCtD
Mercaptopurine—ABCC4—lymph node—urinary bladder cancer	0.000325	0.00476	CbGeAlD
Mercaptopurine—Pancytopenia—Gemcitabine—urinary bladder cancer	0.000322	0.00261	CcSEcCtD
Mercaptopurine—Pancytopenia—Fluorouracil—urinary bladder cancer	0.000317	0.00257	CcSEcCtD
Mercaptopurine—Diarrhoea—Mitomycin—urinary bladder cancer	0.000312	0.00253	CcSEcCtD
Mercaptopurine—Pancreatitis—Cisplatin—urinary bladder cancer	0.00031	0.00252	CcSEcCtD
Mercaptopurine—Liver injury—Epirubicin—urinary bladder cancer	0.000308	0.0025	CcSEcCtD
Mercaptopurine—Pancytopenia—Cisplatin—urinary bladder cancer	0.000301	0.00244	CcSEcCtD
Mercaptopurine—Hyperuricaemia—Methotrexate—urinary bladder cancer	0.000298	0.00242	CcSEcCtD
Mercaptopurine—Stomatitis—Gemcitabine—urinary bladder cancer	0.000295	0.00239	CcSEcCtD
Mercaptopurine—Ulcer—Methotrexate—urinary bladder cancer	0.000293	0.00237	CcSEcCtD
Mercaptopurine—Immune system disorder—Thiotepa—urinary bladder cancer	0.000292	0.00237	CcSEcCtD
Mercaptopurine—Vomiting—Mitomycin—urinary bladder cancer	0.00029	0.00235	CcSEcCtD
Mercaptopurine—Stomatitis—Fluorouracil—urinary bladder cancer	0.00029	0.00235	CcSEcCtD
Mercaptopurine—Rash—Mitomycin—urinary bladder cancer	0.000288	0.00233	CcSEcCtD
Mercaptopurine—Dermatitis—Mitomycin—urinary bladder cancer	0.000287	0.00233	CcSEcCtD
Mercaptopurine—Hepatobiliary disease—Gemcitabine—urinary bladder cancer	0.000286	0.00232	CcSEcCtD
Mercaptopurine—Alopecia—Thiotepa—urinary bladder cancer	0.000285	0.00231	CcSEcCtD
Mercaptopurine—Liver injury—Doxorubicin—urinary bladder cancer	0.000285	0.00231	CcSEcCtD
Mercaptopurine—Blood uric acid increased—Methotrexate—urinary bladder cancer	0.000282	0.00229	CcSEcCtD
Mercaptopurine—Malnutrition—Thiotepa—urinary bladder cancer	0.000281	0.00228	CcSEcCtD
Mercaptopurine—Hyperuricaemia—Epirubicin—urinary bladder cancer	0.000279	0.00226	CcSEcCtD
Mercaptopurine—Pancytopenia—Etoposide—urinary bladder cancer	0.000275	0.00223	CcSEcCtD
Mercaptopurine—Stomatitis—Cisplatin—urinary bladder cancer	0.000275	0.00223	CcSEcCtD
Mercaptopurine—Ulcer—Epirubicin—urinary bladder cancer	0.000274	0.00222	CcSEcCtD
Mercaptopurine—Nausea—Mitomycin—urinary bladder cancer	0.000271	0.0022	CcSEcCtD
Mercaptopurine—Hepatobiliary disease—Cisplatin—urinary bladder cancer	0.000267	0.00216	CcSEcCtD
Mercaptopurine—Blood uric acid increased—Epirubicin—urinary bladder cancer	0.000264	0.00214	CcSEcCtD
Mercaptopurine—Anaemia—Thiotepa—urinary bladder cancer	0.00026	0.00211	CcSEcCtD
Mercaptopurine—Hepatocellular injury—Epirubicin—urinary bladder cancer	0.000259	0.0021	CcSEcCtD
Mercaptopurine—Hyperuricaemia—Doxorubicin—urinary bladder cancer	0.000258	0.00209	CcSEcCtD
Mercaptopurine—Ulcer—Doxorubicin—urinary bladder cancer	0.000253	0.00205	CcSEcCtD
Mercaptopurine—Stomatitis—Etoposide—urinary bladder cancer	0.000252	0.00204	CcSEcCtD
Mercaptopurine—Leukopenia—Thiotepa—urinary bladder cancer	0.000252	0.00204	CcSEcCtD
Mercaptopurine—Mouth ulceration—Methotrexate—urinary bladder cancer	0.00025	0.00203	CcSEcCtD
Mercaptopurine—Neoplasm—Methotrexate—urinary bladder cancer	0.00025	0.00203	CcSEcCtD
Mercaptopurine—Candida infection—Epirubicin—urinary bladder cancer	0.000247	0.002	CcSEcCtD
Mercaptopurine—Immune system disorder—Gemcitabine—urinary bladder cancer	0.000245	0.00199	CcSEcCtD
Mercaptopurine—Hepatobiliary disease—Etoposide—urinary bladder cancer	0.000244	0.00198	CcSEcCtD
Mercaptopurine—Blood uric acid increased—Doxorubicin—urinary bladder cancer	0.000244	0.00198	CcSEcCtD
Mercaptopurine—Sepsis—Methotrexate—urinary bladder cancer	0.00024	0.00195	CcSEcCtD
Mercaptopurine—Alopecia—Gemcitabine—urinary bladder cancer	0.00024	0.00195	CcSEcCtD
Mercaptopurine—Hepatocellular injury—Doxorubicin—urinary bladder cancer	0.00024	0.00194	CcSEcCtD
Mercaptopurine—Arthralgia—Thiotepa—urinary bladder cancer	0.000239	0.00194	CcSEcCtD
Mercaptopurine—Unspecified disorder of skin and subcutaneous tissue—Thiotepa—urinary bladder cancer	0.000238	0.00193	CcSEcCtD
Mercaptopurine—Alopecia—Fluorouracil—urinary bladder cancer	0.000236	0.00191	CcSEcCtD
Mercaptopurine—Neoplasm—Epirubicin—urinary bladder cancer	0.000234	0.0019	CcSEcCtD
Mercaptopurine—Mouth ulceration—Epirubicin—urinary bladder cancer	0.000234	0.0019	CcSEcCtD
Mercaptopurine—Candida infection—Doxorubicin—urinary bladder cancer	0.000229	0.00186	CcSEcCtD
Mercaptopurine—Immune system disorder—Cisplatin—urinary bladder cancer	0.000229	0.00185	CcSEcCtD
Mercaptopurine—Sepsis—Epirubicin—urinary bladder cancer	0.000225	0.00182	CcSEcCtD
Mercaptopurine—Thrombocytopenia—Thiotepa—urinary bladder cancer	0.000225	0.00182	CcSEcCtD
Mercaptopurine—Alopecia—Cisplatin—urinary bladder cancer	0.000224	0.00181	CcSEcCtD
Mercaptopurine—Skin disorder—Thiotepa—urinary bladder cancer	0.000223	0.00181	CcSEcCtD
Mercaptopurine—Malnutrition—Cisplatin—urinary bladder cancer	0.00022	0.00179	CcSEcCtD
Mercaptopurine—Anorexia—Thiotepa—urinary bladder cancer	0.000219	0.00177	CcSEcCtD
Mercaptopurine—Anaemia—Gemcitabine—urinary bladder cancer	0.000219	0.00177	CcSEcCtD
Mercaptopurine—Neoplasm—Doxorubicin—urinary bladder cancer	0.000217	0.00176	CcSEcCtD
Mercaptopurine—Mouth ulceration—Doxorubicin—urinary bladder cancer	0.000217	0.00176	CcSEcCtD
Mercaptopurine—Anaemia—Fluorouracil—urinary bladder cancer	0.000215	0.00174	CcSEcCtD
Mercaptopurine—Leukopenia—Gemcitabine—urinary bladder cancer	0.000212	0.00172	CcSEcCtD
Mercaptopurine—Immune system disorder—Etoposide—urinary bladder cancer	0.00021	0.0017	CcSEcCtD
Mercaptopurine—Musculoskeletal discomfort—Thiotepa—urinary bladder cancer	0.000209	0.0017	CcSEcCtD
Mercaptopurine—Leukopenia—Fluorouracil—urinary bladder cancer	0.000208	0.00169	CcSEcCtD
Mercaptopurine—Sepsis—Doxorubicin—urinary bladder cancer	0.000208	0.00169	CcSEcCtD
Mercaptopurine—Alopecia—Etoposide—urinary bladder cancer	0.000205	0.00166	CcSEcCtD
Mercaptopurine—Anaemia—Cisplatin—urinary bladder cancer	0.000204	0.00165	CcSEcCtD
Mercaptopurine—Arthralgia—Gemcitabine—urinary bladder cancer	0.000201	0.00163	CcSEcCtD
Mercaptopurine—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—urinary bladder cancer	0.0002	0.00162	CcSEcCtD
Mercaptopurine—Decreased appetite—Thiotepa—urinary bladder cancer	0.0002	0.00162	CcSEcCtD
Mercaptopurine—Gastrointestinal disorder—Thiotepa—urinary bladder cancer	0.000198	0.00161	CcSEcCtD
Mercaptopurine—Leukopenia—Cisplatin—urinary bladder cancer	0.000197	0.0016	CcSEcCtD
Mercaptopurine—Oedema—Gemcitabine—urinary bladder cancer	0.000193	0.00157	CcSEcCtD
Mercaptopurine—Oedema—Fluorouracil—urinary bladder cancer	0.00019	0.00154	CcSEcCtD
Mercaptopurine—Thrombocytopenia—Gemcitabine—urinary bladder cancer	0.000189	0.00153	CcSEcCtD
Mercaptopurine—Skin disorder—Gemcitabine—urinary bladder cancer	0.000188	0.00152	CcSEcCtD
Mercaptopurine—Anaemia—Etoposide—urinary bladder cancer	0.000187	0.00151	CcSEcCtD
Mercaptopurine—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—urinary bladder cancer	0.000186	0.00151	CcSEcCtD
Mercaptopurine—Thrombocytopenia—Fluorouracil—urinary bladder cancer	0.000186	0.00151	CcSEcCtD
Mercaptopurine—Anorexia—Gemcitabine—urinary bladder cancer	0.000184	0.00149	CcSEcCtD
Mercaptopurine—Breast disorder—Methotrexate—urinary bladder cancer	0.000182	0.00147	CcSEcCtD
Mercaptopurine—Body temperature increased—Thiotepa—urinary bladder cancer	0.000181	0.00147	CcSEcCtD
Mercaptopurine—Anorexia—Fluorouracil—urinary bladder cancer	0.000181	0.00147	CcSEcCtD
Mercaptopurine—Leukopenia—Etoposide—urinary bladder cancer	0.000181	0.00147	CcSEcCtD
Mercaptopurine—Oedema—Cisplatin—urinary bladder cancer	0.00018	0.00146	CcSEcCtD
Mercaptopurine—Thrombocytopenia—Cisplatin—urinary bladder cancer	0.000176	0.00143	CcSEcCtD
Mercaptopurine—Musculoskeletal discomfort—Gemcitabine—urinary bladder cancer	0.000176	0.00143	CcSEcCtD
Mercaptopurine—Skin disorder—Cisplatin—urinary bladder cancer	0.000175	0.00142	CcSEcCtD
Mercaptopurine—Musculoskeletal discomfort—Fluorouracil—urinary bladder cancer	0.000173	0.0014	CcSEcCtD
Mercaptopurine—Anorexia—Cisplatin—urinary bladder cancer	0.000172	0.00139	CcSEcCtD
Mercaptopurine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—urinary bladder cancer	0.000171	0.00138	CcSEcCtD
Mercaptopurine—Pancreatitis—Methotrexate—urinary bladder cancer	0.00017	0.00138	CcSEcCtD
Mercaptopurine—Breast disorder—Epirubicin—urinary bladder cancer	0.00017	0.00138	CcSEcCtD
Mercaptopurine—Hypersensitivity—Thiotepa—urinary bladder cancer	0.000169	0.00137	CcSEcCtD
Mercaptopurine—Decreased appetite—Gemcitabine—urinary bladder cancer	0.000168	0.00136	CcSEcCtD
Mercaptopurine—Gastrointestinal disorder—Gemcitabine—urinary bladder cancer	0.000167	0.00135	CcSEcCtD
Mercaptopurine—Decreased appetite—Fluorouracil—urinary bladder cancer	0.000165	0.00134	CcSEcCtD
Mercaptopurine—Pancytopenia—Methotrexate—urinary bladder cancer	0.000165	0.00134	CcSEcCtD
Mercaptopurine—Musculoskeletal discomfort—Cisplatin—urinary bladder cancer	0.000164	0.00133	CcSEcCtD
Mercaptopurine—Gastrointestinal disorder—Fluorouracil—urinary bladder cancer	0.000164	0.00133	CcSEcCtD
Mercaptopurine—Thrombocytopenia—Etoposide—urinary bladder cancer	0.000161	0.00131	CcSEcCtD
Mercaptopurine—Skin disorder—Etoposide—urinary bladder cancer	0.00016	0.0013	CcSEcCtD
Mercaptopurine—Pancreatitis—Epirubicin—urinary bladder cancer	0.000159	0.00129	CcSEcCtD
Mercaptopurine—Breast disorder—Doxorubicin—urinary bladder cancer	0.000157	0.00127	CcSEcCtD
Mercaptopurine—Anorexia—Etoposide—urinary bladder cancer	0.000157	0.00127	CcSEcCtD
Mercaptopurine—Diarrhoea—Thiotepa—urinary bladder cancer	0.000157	0.00127	CcSEcCtD
Mercaptopurine—Decreased appetite—Cisplatin—urinary bladder cancer	0.000156	0.00127	CcSEcCtD
Mercaptopurine—Gastrointestinal disorder—Cisplatin—urinary bladder cancer	0.000155	0.00126	CcSEcCtD
Mercaptopurine—ABCC5—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	0.000155	0.00196	CbGpPWpGaD
Mercaptopurine—Pancytopenia—Epirubicin—urinary bladder cancer	0.000154	0.00125	CcSEcCtD
Mercaptopurine—Body temperature increased—Gemcitabine—urinary bladder cancer	0.000153	0.00124	CcSEcCtD
Mercaptopurine—Stomatitis—Methotrexate—urinary bladder cancer	0.000151	0.00122	CcSEcCtD
Mercaptopurine—Body temperature increased—Fluorouracil—urinary bladder cancer	0.00015	0.00122	CcSEcCtD
Mercaptopurine—Pancreatitis—Doxorubicin—urinary bladder cancer	0.000147	0.0012	CcSEcCtD
Mercaptopurine—Hepatobiliary disease—Methotrexate—urinary bladder cancer	0.000146	0.00119	CcSEcCtD
Mercaptopurine—Vomiting—Thiotepa—urinary bladder cancer	0.000146	0.00118	CcSEcCtD
Mercaptopurine—HPRT1—Metabolism—CYP4B1—urinary bladder cancer	0.000146	0.00184	CbGpPWpGaD
Mercaptopurine—PPAT—Metabolism—CYP4B1—urinary bladder cancer	0.000146	0.00184	CbGpPWpGaD
Mercaptopurine—Rash—Thiotepa—urinary bladder cancer	0.000145	0.00117	CcSEcCtD
Mercaptopurine—Dermatitis—Thiotepa—urinary bladder cancer	0.000145	0.00117	CcSEcCtD
Mercaptopurine—ABCC5—Fluoropyrimidine Activity—TP53—urinary bladder cancer	0.000144	0.00182	CbGpPWpGaD
Mercaptopurine—Decreased appetite—Etoposide—urinary bladder cancer	0.000143	0.00116	CcSEcCtD
Mercaptopurine—Pancytopenia—Doxorubicin—urinary bladder cancer	0.000143	0.00116	CcSEcCtD
Mercaptopurine—Gastrointestinal disorder—Etoposide—urinary bladder cancer	0.000142	0.00115	CcSEcCtD
Mercaptopurine—Body temperature increased—Cisplatin—urinary bladder cancer	0.000142	0.00115	CcSEcCtD
Mercaptopurine—ABCC5—NRF2 pathway—GSTP1—urinary bladder cancer	0.000142	0.0018	CbGpPWpGaD
Mercaptopurine—Stomatitis—Epirubicin—urinary bladder cancer	0.000141	0.00115	CcSEcCtD
Mercaptopurine—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.00014	0.00113	CcSEcCtD
Mercaptopurine—PPAT—Metabolism—SLC19A1—urinary bladder cancer	0.000138	0.00174	CbGpPWpGaD
Mercaptopurine—HPRT1—Metabolism—SLC19A1—urinary bladder cancer	0.000138	0.00174	CbGpPWpGaD
Mercaptopurine—SLC29A1—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	0.000138	0.00174	CbGpPWpGaD
Mercaptopurine—Hepatobiliary disease—Epirubicin—urinary bladder cancer	0.000137	0.00111	CcSEcCtD
Mercaptopurine—Nausea—Thiotepa—urinary bladder cancer	0.000136	0.00111	CcSEcCtD
Mercaptopurine—HPRT1—Metabolism—PRSS3—urinary bladder cancer	0.000134	0.0017	CbGpPWpGaD
Mercaptopurine—PPAT—Metabolism—PRSS3—urinary bladder cancer	0.000134	0.0017	CbGpPWpGaD
Mercaptopurine—SLC29A2—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	0.000134	0.0017	CbGpPWpGaD
Mercaptopurine—ABCC5—Carbohydrate metabolism—ENO2—urinary bladder cancer	0.000134	0.00169	CbGpPWpGaD
Mercaptopurine—Hypersensitivity—Cisplatin—urinary bladder cancer	0.000133	0.00107	CcSEcCtD
Mercaptopurine—Diarrhoea—Gemcitabine—urinary bladder cancer	0.000132	0.00107	CcSEcCtD
Mercaptopurine—TPMT—Metabolism—GSTZ1—urinary bladder cancer	0.000131	0.00166	CbGpPWpGaD
Mercaptopurine—Stomatitis—Doxorubicin—urinary bladder cancer	0.000131	0.00106	CcSEcCtD
Mercaptopurine—ABCC5—NRF2 pathway—GSTM1—urinary bladder cancer	0.000131	0.00165	CbGpPWpGaD
Mercaptopurine—Body temperature increased—Etoposide—urinary bladder cancer	0.00013	0.00106	CcSEcCtD
Mercaptopurine—Diarrhoea—Fluorouracil—urinary bladder cancer	0.00013	0.00105	CcSEcCtD
Mercaptopurine—Hepatobiliary disease—Doxorubicin—urinary bladder cancer	0.000127	0.00103	CcSEcCtD
Mercaptopurine—Immune system disorder—Methotrexate—urinary bladder cancer	0.000126	0.00102	CcSEcCtD
Mercaptopurine—AOX1—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—urinary bladder cancer	0.000125	0.00158	CbGpPWpGaD
Mercaptopurine—TPMT—Metabolism—GSTO2—urinary bladder cancer	0.000125	0.00158	CbGpPWpGaD
Mercaptopurine—TPMT—Metabolism—NAT1—urinary bladder cancer	0.000125	0.00158	CbGpPWpGaD
Mercaptopurine—SLC28A3—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	0.000125	0.00158	CbGpPWpGaD
Mercaptopurine—Diarrhoea—Cisplatin—urinary bladder cancer	0.000123	0.000998	CcSEcCtD
Mercaptopurine—Alopecia—Methotrexate—urinary bladder cancer	0.000123	0.000996	CcSEcCtD
Mercaptopurine—Vomiting—Gemcitabine—urinary bladder cancer	0.000123	0.000995	CcSEcCtD
Mercaptopurine—Rash—Gemcitabine—urinary bladder cancer	0.000122	0.000987	CcSEcCtD
Mercaptopurine—Dermatitis—Gemcitabine—urinary bladder cancer	0.000122	0.000986	CcSEcCtD
Mercaptopurine—Hypersensitivity—Etoposide—urinary bladder cancer	0.000121	0.000985	CcSEcCtD
Mercaptopurine—Malnutrition—Methotrexate—urinary bladder cancer	0.000121	0.000981	CcSEcCtD
Mercaptopurine—Vomiting—Fluorouracil—urinary bladder cancer	0.000121	0.000979	CcSEcCtD
Mercaptopurine—Rash—Fluorouracil—urinary bladder cancer	0.00012	0.00097	CcSEcCtD
Mercaptopurine—Dermatitis—Fluorouracil—urinary bladder cancer	0.00012	0.000969	CcSEcCtD
Mercaptopurine—SLC28A2—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	0.000119	0.00151	CbGpPWpGaD
Mercaptopurine—ABCC4—NRF2 pathway—NQO1—urinary bladder cancer	0.000118	0.0015	CbGpPWpGaD
Mercaptopurine—Immune system disorder—Epirubicin—urinary bladder cancer	0.000117	0.000953	CcSEcCtD
Mercaptopurine—XDH—Selenium Micronutrient Network—PTGS2—urinary bladder cancer	0.000115	0.00146	CbGpPWpGaD
Mercaptopurine—Alopecia—Epirubicin—urinary bladder cancer	0.000115	0.000932	CcSEcCtD
Mercaptopurine—Nausea—Gemcitabine—urinary bladder cancer	0.000115	0.00093	CcSEcCtD
Mercaptopurine—Vomiting—Cisplatin—urinary bladder cancer	0.000114	0.000928	CcSEcCtD
Mercaptopurine—TPMT—Metabolism—UGT2B7—urinary bladder cancer	0.000114	0.00144	CbGpPWpGaD
Mercaptopurine—Rash—Cisplatin—urinary bladder cancer	0.000113	0.00092	CcSEcCtD
Mercaptopurine—Dermatitis—Cisplatin—urinary bladder cancer	0.000113	0.000919	CcSEcCtD
Mercaptopurine—Malnutrition—Epirubicin—urinary bladder cancer	0.000113	0.000918	CcSEcCtD
Mercaptopurine—Diarrhoea—Etoposide—urinary bladder cancer	0.000113	0.000915	CcSEcCtD
Mercaptopurine—Nausea—Fluorouracil—urinary bladder cancer	0.000113	0.000914	CcSEcCtD
Mercaptopurine—Anaemia—Methotrexate—urinary bladder cancer	0.000112	0.000907	CcSEcCtD
Mercaptopurine—ABCC5—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	0.000112	0.00141	CbGpPWpGaD
Mercaptopurine—SLC22A8—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	0.000112	0.00141	CbGpPWpGaD
Mercaptopurine—Immune system disorder—Doxorubicin—urinary bladder cancer	0.000109	0.000881	CcSEcCtD
Mercaptopurine—Leukopenia—Methotrexate—urinary bladder cancer	0.000108	0.000878	CcSEcCtD
Mercaptopurine—PPAT—Metabolism—TYMP—urinary bladder cancer	0.000107	0.00136	CbGpPWpGaD
Mercaptopurine—HPRT1—Metabolism—TYMP—urinary bladder cancer	0.000107	0.00136	CbGpPWpGaD
Mercaptopurine—ABCC4—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	0.000107	0.00136	CbGpPWpGaD
Mercaptopurine—Nausea—Cisplatin—urinary bladder cancer	0.000107	0.000867	CcSEcCtD
Mercaptopurine—Alopecia—Doxorubicin—urinary bladder cancer	0.000106	0.000862	CcSEcCtD
Mercaptopurine—Vomiting—Etoposide—urinary bladder cancer	0.000105	0.00085	CcSEcCtD
Mercaptopurine—Malnutrition—Doxorubicin—urinary bladder cancer	0.000105	0.000849	CcSEcCtD
Mercaptopurine—Anaemia—Epirubicin—urinary bladder cancer	0.000105	0.000849	CcSEcCtD
Mercaptopurine—Rash—Etoposide—urinary bladder cancer	0.000104	0.000843	CcSEcCtD
Mercaptopurine—Dermatitis—Etoposide—urinary bladder cancer	0.000104	0.000842	CcSEcCtD
Mercaptopurine—Arthralgia—Methotrexate—urinary bladder cancer	0.000103	0.000835	CcSEcCtD
Mercaptopurine—TPMT—Metabolism—CYP4B1—urinary bladder cancer	0.000103	0.0013	CbGpPWpGaD
Mercaptopurine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—urinary bladder cancer	0.000102	0.000829	CcSEcCtD
Mercaptopurine—Leukopenia—Epirubicin—urinary bladder cancer	0.000101	0.000822	CcSEcCtD
Mercaptopurine—ABCC4—Fluoropyrimidine Activity—TP53—urinary bladder cancer	9.98e-05	0.00126	CbGpPWpGaD
Mercaptopurine—ABCC4—Platelet degranulation—IGF1—urinary bladder cancer	9.96e-05	0.00126	CbGpPWpGaD
Mercaptopurine—ABCC4—NRF2 pathway—GSTP1—urinary bladder cancer	9.85e-05	0.00125	CbGpPWpGaD
Mercaptopurine—Nausea—Etoposide—urinary bladder cancer	9.79e-05	0.000794	CcSEcCtD
Mercaptopurine—AOX1—Disease—GSTO2—urinary bladder cancer	9.7e-05	0.00123	CbGpPWpGaD
Mercaptopurine—PPAT—Metabolism—NAT2—urinary bladder cancer	9.69e-05	0.00123	CbGpPWpGaD
Mercaptopurine—HPRT1—Metabolism—NAT2—urinary bladder cancer	9.69e-05	0.00123	CbGpPWpGaD
Mercaptopurine—TPMT—Metabolism—SLC19A1—urinary bladder cancer	9.69e-05	0.00123	CbGpPWpGaD
Mercaptopurine—Anaemia—Doxorubicin—urinary bladder cancer	9.68e-05	0.000785	CcSEcCtD
Mercaptopurine—Thrombocytopenia—Methotrexate—urinary bladder cancer	9.67e-05	0.000784	CcSEcCtD
Mercaptopurine—Arthralgia—Epirubicin—urinary bladder cancer	9.64e-05	0.000782	CcSEcCtD
Mercaptopurine—Skin disorder—Methotrexate—urinary bladder cancer	9.59e-05	0.000778	CcSEcCtD
Mercaptopurine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—urinary bladder cancer	9.57e-05	0.000776	CcSEcCtD
Mercaptopurine—ABCC4—Response to elevated platelet cytosolic Ca2+—IGF1—urinary bladder cancer	9.49e-05	0.0012	CbGpPWpGaD
Mercaptopurine—TPMT—Metabolism—PRSS3—urinary bladder cancer	9.44e-05	0.0012	CbGpPWpGaD
Mercaptopurine—Anorexia—Methotrexate—urinary bladder cancer	9.41e-05	0.000763	CcSEcCtD
Mercaptopurine—Leukopenia—Doxorubicin—urinary bladder cancer	9.38e-05	0.00076	CcSEcCtD
Mercaptopurine—SLC29A1—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	9.29e-05	0.00118	CbGpPWpGaD
Mercaptopurine—Oedema—Epirubicin—urinary bladder cancer	9.24e-05	0.000749	CcSEcCtD
Mercaptopurine—ABCC5—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	9.11e-05	0.00115	CbGpPWpGaD
Mercaptopurine—ABCC4—NRF2 pathway—GSTM1—urinary bladder cancer	9.05e-05	0.00115	CbGpPWpGaD
Mercaptopurine—Thrombocytopenia—Epirubicin—urinary bladder cancer	9.05e-05	0.000734	CcSEcCtD
Mercaptopurine—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	9e-05	0.000729	CcSEcCtD
Mercaptopurine—Skin disorder—Epirubicin—urinary bladder cancer	8.98e-05	0.000728	CcSEcCtD
Mercaptopurine—Arthralgia—Doxorubicin—urinary bladder cancer	8.92e-05	0.000723	CcSEcCtD
Mercaptopurine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—urinary bladder cancer	8.86e-05	0.000718	CcSEcCtD
Mercaptopurine—Anorexia—Epirubicin—urinary bladder cancer	8.81e-05	0.000714	CcSEcCtD
Mercaptopurine—ABCC5—Disease—GSTO2—urinary bladder cancer	8.64e-05	0.00109	CbGpPWpGaD
Mercaptopurine—Decreased appetite—Methotrexate—urinary bladder cancer	8.58e-05	0.000696	CcSEcCtD
Mercaptopurine—AOX1—Metabolism—GSTZ1—urinary bladder cancer	8.57e-05	0.00108	CbGpPWpGaD
Mercaptopurine—Oedema—Doxorubicin—urinary bladder cancer	8.55e-05	0.000693	CcSEcCtD
Mercaptopurine—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	8.53e-05	0.000691	CcSEcCtD
Mercaptopurine—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	8.42e-05	0.000683	CcSEcCtD
Mercaptopurine—Thrombocytopenia—Doxorubicin—urinary bladder cancer	8.37e-05	0.000679	CcSEcCtD
Mercaptopurine—PPAT—Metabolism—RRM2—urinary bladder cancer	8.37e-05	0.00106	CbGpPWpGaD
Mercaptopurine—HPRT1—Metabolism—RRM2—urinary bladder cancer	8.37e-05	0.00106	CbGpPWpGaD
Mercaptopurine—Skin disorder—Doxorubicin—urinary bladder cancer	8.31e-05	0.000673	CcSEcCtD
Mercaptopurine—Anorexia—Doxorubicin—urinary bladder cancer	8.15e-05	0.000661	CcSEcCtD
Mercaptopurine—AOX1—Metabolism—GSTO2—urinary bladder cancer	8.12e-05	0.00103	CbGpPWpGaD
Mercaptopurine—AOX1—Metabolism—NAT1—urinary bladder cancer	8.12e-05	0.00103	CbGpPWpGaD
Mercaptopurine—SLC22A8—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	8.08e-05	0.00102	CbGpPWpGaD
Mercaptopurine—Decreased appetite—Epirubicin—urinary bladder cancer	8.03e-05	0.000651	CcSEcCtD
Mercaptopurine—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	7.98e-05	0.000647	CcSEcCtD
Mercaptopurine—XDH—Metabolism—GSTZ1—urinary bladder cancer	7.96e-05	0.00101	CbGpPWpGaD
Mercaptopurine—Body temperature increased—Methotrexate—urinary bladder cancer	7.81e-05	0.000633	CcSEcCtD
Mercaptopurine—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	7.79e-05	0.000632	CcSEcCtD
Mercaptopurine—XDH—Selenium Micronutrient Network—TNF—urinary bladder cancer	7.77e-05	0.000984	CbGpPWpGaD
Mercaptopurine—PPAT—Metabolism—HPGDS—urinary bladder cancer	7.75e-05	0.000981	CbGpPWpGaD
Mercaptopurine—HPRT1—Metabolism—ENO2—urinary bladder cancer	7.75e-05	0.000981	CbGpPWpGaD
Mercaptopurine—PPAT—Metabolism—ENO2—urinary bladder cancer	7.75e-05	0.000981	CbGpPWpGaD
Mercaptopurine—HPRT1—Metabolism—HPGDS—urinary bladder cancer	7.75e-05	0.000981	CbGpPWpGaD
Mercaptopurine—ABCC4—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	7.75e-05	0.000981	CbGpPWpGaD
Mercaptopurine—ABCC5—Metabolism—GSTZ1—urinary bladder cancer	7.64e-05	0.000967	CbGpPWpGaD
Mercaptopurine—TPMT—Metabolism—TYMP—urinary bladder cancer	7.55e-05	0.000956	CbGpPWpGaD
Mercaptopurine—XDH—Metabolism—GSTO2—urinary bladder cancer	7.55e-05	0.000956	CbGpPWpGaD
Mercaptopurine—XDH—Metabolism—NAT1—urinary bladder cancer	7.55e-05	0.000956	CbGpPWpGaD
Mercaptopurine—AOX1—Disease—SLC19A1—urinary bladder cancer	7.54e-05	0.000955	CbGpPWpGaD
Mercaptopurine—HPRT1—Metabolism—GSTT1—urinary bladder cancer	7.51e-05	0.000952	CbGpPWpGaD
Mercaptopurine—PPAT—Metabolism—GSTT1—urinary bladder cancer	7.51e-05	0.000952	CbGpPWpGaD
Mercaptopurine—Decreased appetite—Doxorubicin—urinary bladder cancer	7.43e-05	0.000603	CcSEcCtD
Mercaptopurine—AOX1—Metabolism—UGT2B7—urinary bladder cancer	7.43e-05	0.000941	CbGpPWpGaD
Mercaptopurine—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	7.38e-05	0.000599	CcSEcCtD
Mercaptopurine—AOX1—Disease—PRSS3—urinary bladder cancer	7.35e-05	0.000931	CbGpPWpGaD
Mercaptopurine—Body temperature increased—Epirubicin—urinary bladder cancer	7.31e-05	0.000592	CcSEcCtD
Mercaptopurine—Hypersensitivity—Methotrexate—urinary bladder cancer	7.28e-05	0.00059	CcSEcCtD
Mercaptopurine—ABCC5—Metabolism—GSTO2—urinary bladder cancer	7.24e-05	0.000917	CbGpPWpGaD
Mercaptopurine—ABCC5—Metabolism—NAT1—urinary bladder cancer	7.24e-05	0.000917	CbGpPWpGaD
Mercaptopurine—AOX1—Disease—HDAC4—urinary bladder cancer	7.01e-05	0.000888	CbGpPWpGaD
Mercaptopurine—XDH—Metabolism—UGT2B7—urinary bladder cancer	6.91e-05	0.000874	CbGpPWpGaD
Mercaptopurine—TPMT—Metabolism—NAT2—urinary bladder cancer	6.83e-05	0.000865	CbGpPWpGaD
Mercaptopurine—Hypersensitivity—Epirubicin—urinary bladder cancer	6.81e-05	0.000552	CcSEcCtD
Mercaptopurine—Body temperature increased—Doxorubicin—urinary bladder cancer	6.76e-05	0.000548	CcSEcCtD
Mercaptopurine—Diarrhoea—Methotrexate—urinary bladder cancer	6.76e-05	0.000548	CcSEcCtD
Mercaptopurine—ABCC5—Disease—SLC19A1—urinary bladder cancer	6.72e-05	0.000851	CbGpPWpGaD
Mercaptopurine—AOX1—Metabolism—CYP4B1—urinary bladder cancer	6.69e-05	0.000847	CbGpPWpGaD
Mercaptopurine—ABCC5—Metabolism—UGT2B7—urinary bladder cancer	6.62e-05	0.000838	CbGpPWpGaD
Mercaptopurine—SLC22A8—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	6.59e-05	0.000834	CbGpPWpGaD
Mercaptopurine—ABCC5—Disease—PRSS3—urinary bladder cancer	6.55e-05	0.000829	CbGpPWpGaD
Mercaptopurine—Diarrhoea—Epirubicin—urinary bladder cancer	6.32e-05	0.000513	CcSEcCtD
Mercaptopurine—AOX1—Metabolism—SLC19A1—urinary bladder cancer	6.32e-05	0.0008	CbGpPWpGaD
Mercaptopurine—ABCC4—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	6.31e-05	0.000799	CbGpPWpGaD
Mercaptopurine—Hypersensitivity—Doxorubicin—urinary bladder cancer	6.3e-05	0.000511	CcSEcCtD
Mercaptopurine—Vomiting—Methotrexate—urinary bladder cancer	6.28e-05	0.000509	CcSEcCtD
Mercaptopurine—SLC29A2—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	6.27e-05	0.000794	CbGpPWpGaD
Mercaptopurine—ABCC5—Disease—HDAC4—urinary bladder cancer	6.25e-05	0.000791	CbGpPWpGaD
Mercaptopurine—PPAT—Metabolism—NQO1—urinary bladder cancer	6.25e-05	0.000791	CbGpPWpGaD
Mercaptopurine—HPRT1—Metabolism—NQO1—urinary bladder cancer	6.25e-05	0.000791	CbGpPWpGaD
Mercaptopurine—Rash—Methotrexate—urinary bladder cancer	6.23e-05	0.000505	CcSEcCtD
Mercaptopurine—Dermatitis—Methotrexate—urinary bladder cancer	6.22e-05	0.000504	CcSEcCtD
Mercaptopurine—XDH—Metabolism—CYP4B1—urinary bladder cancer	6.22e-05	0.000787	CbGpPWpGaD
Mercaptopurine—AOX1—Metabolism—PRSS3—urinary bladder cancer	6.16e-05	0.000779	CbGpPWpGaD
Mercaptopurine—ABCC5—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	6.15e-05	0.000779	CbGpPWpGaD
Mercaptopurine—ABCC5—Metabolism—CYP4B1—urinary bladder cancer	5.96e-05	0.000755	CbGpPWpGaD
Mercaptopurine—TPMT—Metabolism—RRM2—urinary bladder cancer	5.89e-05	0.000746	CbGpPWpGaD
Mercaptopurine—Vomiting—Epirubicin—urinary bladder cancer	5.88e-05	0.000476	CcSEcCtD
Mercaptopurine—XDH—Metabolism—SLC19A1—urinary bladder cancer	5.87e-05	0.000744	CbGpPWpGaD
Mercaptopurine—Nausea—Methotrexate—urinary bladder cancer	5.87e-05	0.000476	CcSEcCtD
Mercaptopurine—Diarrhoea—Doxorubicin—urinary bladder cancer	5.85e-05	0.000474	CcSEcCtD
Mercaptopurine—SLC28A3—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	5.83e-05	0.000738	CbGpPWpGaD
Mercaptopurine—Rash—Epirubicin—urinary bladder cancer	5.83e-05	0.000472	CcSEcCtD
Mercaptopurine—Dermatitis—Epirubicin—urinary bladder cancer	5.82e-05	0.000472	CcSEcCtD
Mercaptopurine—XDH—Metabolism—PRSS3—urinary bladder cancer	5.72e-05	0.000725	CbGpPWpGaD
Mercaptopurine—ABCC5—Metabolism—SLC19A1—urinary bladder cancer	5.63e-05	0.000713	CbGpPWpGaD
Mercaptopurine—AOX1—Disease—LIG1—urinary bladder cancer	5.57e-05	0.000705	CbGpPWpGaD
Mercaptopurine—Nausea—Epirubicin—urinary bladder cancer	5.49e-05	0.000445	CcSEcCtD
Mercaptopurine—ABCC5—Metabolism—PRSS3—urinary bladder cancer	5.49e-05	0.000695	CbGpPWpGaD
Mercaptopurine—TPMT—Metabolism—ENO2—urinary bladder cancer	5.46e-05	0.000691	CbGpPWpGaD
Mercaptopurine—TPMT—Metabolism—HPGDS—urinary bladder cancer	5.46e-05	0.000691	CbGpPWpGaD
Mercaptopurine—Vomiting—Doxorubicin—urinary bladder cancer	5.44e-05	0.000441	CcSEcCtD
Mercaptopurine—Rash—Doxorubicin—urinary bladder cancer	5.39e-05	0.000437	CcSEcCtD
Mercaptopurine—Dermatitis—Doxorubicin—urinary bladder cancer	5.39e-05	0.000437	CcSEcCtD
Mercaptopurine—TPMT—Metabolism—GSTT1—urinary bladder cancer	5.29e-05	0.00067	CbGpPWpGaD
Mercaptopurine—PPAT—Metabolism—GSTP1—urinary bladder cancer	5.21e-05	0.00066	CbGpPWpGaD
Mercaptopurine—HPRT1—Metabolism—GSTP1—urinary bladder cancer	5.21e-05	0.00066	CbGpPWpGaD
Mercaptopurine—Nausea—Doxorubicin—urinary bladder cancer	5.08e-05	0.000412	CcSEcCtD
Mercaptopurine—ABCC5—Disease—LIG1—urinary bladder cancer	4.96e-05	0.000629	CbGpPWpGaD
Mercaptopurine—AOX1—Metabolism—TYMP—urinary bladder cancer	4.92e-05	0.000623	CbGpPWpGaD
Mercaptopurine—HPRT1—Metabolism—TYMS—urinary bladder cancer	4.84e-05	0.000613	CbGpPWpGaD
Mercaptopurine—PPAT—Metabolism—TYMS—urinary bladder cancer	4.84e-05	0.000613	CbGpPWpGaD
Mercaptopurine—HPRT1—Metabolism—NCOR1—urinary bladder cancer	4.79e-05	0.000606	CbGpPWpGaD
Mercaptopurine—HPRT1—Metabolism—GSTM1—urinary bladder cancer	4.79e-05	0.000606	CbGpPWpGaD
Mercaptopurine—PPAT—Metabolism—NCOR1—urinary bladder cancer	4.79e-05	0.000606	CbGpPWpGaD
Mercaptopurine—PPAT—Metabolism—GSTM1—urinary bladder cancer	4.79e-05	0.000606	CbGpPWpGaD
Mercaptopurine—PPAT—Metabolism—GPX1—urinary bladder cancer	4.58e-05	0.00058	CbGpPWpGaD
Mercaptopurine—HPRT1—Metabolism—GPX1—urinary bladder cancer	4.58e-05	0.00058	CbGpPWpGaD
Mercaptopurine—XDH—Metabolism—TYMP—urinary bladder cancer	4.57e-05	0.000579	CbGpPWpGaD
Mercaptopurine—PPAT—Metabolism—ERCC2—urinary bladder cancer	4.5e-05	0.00057	CbGpPWpGaD
Mercaptopurine—HPRT1—Metabolism—ERCC2—urinary bladder cancer	4.5e-05	0.00057	CbGpPWpGaD
Mercaptopurine—AOX1—Metabolism—NAT2—urinary bladder cancer	4.45e-05	0.000563	CbGpPWpGaD
Mercaptopurine—SLC22A8—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	4.45e-05	0.000563	CbGpPWpGaD
Mercaptopurine—ABCC4—Platelet activation, signaling and aggregation—IGF1—urinary bladder cancer	4.42e-05	0.000559	CbGpPWpGaD
Mercaptopurine—TPMT—Metabolism—NQO1—urinary bladder cancer	4.4e-05	0.000557	CbGpPWpGaD
Mercaptopurine—ABCC5—Metabolism—TYMP—urinary bladder cancer	4.39e-05	0.000555	CbGpPWpGaD
Mercaptopurine—SLC29A1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	4.35e-05	0.00055	CbGpPWpGaD
Mercaptopurine—ABCC4—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	4.26e-05	0.00054	CbGpPWpGaD
Mercaptopurine—AOX1—Disease—ENO2—urinary bladder cancer	4.25e-05	0.000538	CbGpPWpGaD
Mercaptopurine—PPAT—Metabolism—MTHFR—urinary bladder cancer	4.23e-05	0.000536	CbGpPWpGaD
Mercaptopurine—HPRT1—Metabolism—MTHFR—urinary bladder cancer	4.23e-05	0.000536	CbGpPWpGaD
Mercaptopurine—XDH—Metabolism—NAT2—urinary bladder cancer	4.14e-05	0.000524	CbGpPWpGaD
Mercaptopurine—ABCC4—Platelet activation, signaling and aggregation—RHOA—urinary bladder cancer	4.05e-05	0.000512	CbGpPWpGaD
Mercaptopurine—AOX1—Disease—RBX1—urinary bladder cancer	4.03e-05	0.00051	CbGpPWpGaD
Mercaptopurine—ABCC5—Metabolism—NAT2—urinary bladder cancer	3.97e-05	0.000502	CbGpPWpGaD
Mercaptopurine—ABCC4—Hemostasis—IFNA2—urinary bladder cancer	3.94e-05	0.000499	CbGpPWpGaD
Mercaptopurine—ABCC4—Ectoderm Differentiation—MYC—urinary bladder cancer	3.87e-05	0.00049	CbGpPWpGaD
Mercaptopurine—AOX1—Metabolism—RRM2—urinary bladder cancer	3.84e-05	0.000486	CbGpPWpGaD
Mercaptopurine—ABCC5—Disease—ENO2—urinary bladder cancer	3.79e-05	0.000479	CbGpPWpGaD
Mercaptopurine—TPMT—Metabolism—GSTP1—urinary bladder cancer	3.67e-05	0.000465	CbGpPWpGaD
Mercaptopurine—AOX1—Disease—JAG1—urinary bladder cancer	3.6e-05	0.000456	CbGpPWpGaD
Mercaptopurine—ABCC5—Disease—RBX1—urinary bladder cancer	3.59e-05	0.000454	CbGpPWpGaD
Mercaptopurine—XDH—Metabolism—RRM2—urinary bladder cancer	3.57e-05	0.000452	CbGpPWpGaD
Mercaptopurine—AOX1—Metabolism—HPGDS—urinary bladder cancer	3.56e-05	0.00045	CbGpPWpGaD
Mercaptopurine—AOX1—Metabolism—ENO2—urinary bladder cancer	3.56e-05	0.00045	CbGpPWpGaD
Mercaptopurine—AOX1—Metabolism—GSTT1—urinary bladder cancer	3.45e-05	0.000437	CbGpPWpGaD
Mercaptopurine—PPAT—Metabolism—PPARG—urinary bladder cancer	3.43e-05	0.000434	CbGpPWpGaD
Mercaptopurine—HPRT1—Metabolism—PPARG—urinary bladder cancer	3.43e-05	0.000434	CbGpPWpGaD
Mercaptopurine—ABCC5—Metabolism—RRM2—urinary bladder cancer	3.42e-05	0.000434	CbGpPWpGaD
Mercaptopurine—TPMT—Metabolism—TYMS—urinary bladder cancer	3.41e-05	0.000432	CbGpPWpGaD
Mercaptopurine—ABCC4—Platelet activation, signaling and aggregation—IL2—urinary bladder cancer	3.39e-05	0.00043	CbGpPWpGaD
Mercaptopurine—TPMT—Metabolism—GSTM1—urinary bladder cancer	3.37e-05	0.000427	CbGpPWpGaD
Mercaptopurine—TPMT—Metabolism—NCOR1—urinary bladder cancer	3.37e-05	0.000427	CbGpPWpGaD
Mercaptopurine—XDH—Metabolism—ENO2—urinary bladder cancer	3.31e-05	0.000419	CbGpPWpGaD
Mercaptopurine—XDH—Metabolism—HPGDS—urinary bladder cancer	3.31e-05	0.000419	CbGpPWpGaD
Mercaptopurine—PPAT—Metabolism—CREBBP—urinary bladder cancer	3.3e-05	0.000417	CbGpPWpGaD
Mercaptopurine—HPRT1—Metabolism—CREBBP—urinary bladder cancer	3.3e-05	0.000417	CbGpPWpGaD
Mercaptopurine—TPMT—Metabolism—GPX1—urinary bladder cancer	3.23e-05	0.000409	CbGpPWpGaD
Mercaptopurine—ABCC5—Disease—JAG1—urinary bladder cancer	3.21e-05	0.000407	CbGpPWpGaD
Mercaptopurine—XDH—Metabolism—GSTT1—urinary bladder cancer	3.21e-05	0.000406	CbGpPWpGaD
Mercaptopurine—TPMT—Metabolism—ERCC2—urinary bladder cancer	3.17e-05	0.000401	CbGpPWpGaD
Mercaptopurine—ABCC5—Metabolism—ENO2—urinary bladder cancer	3.17e-05	0.000401	CbGpPWpGaD
Mercaptopurine—ABCC5—Metabolism—HPGDS—urinary bladder cancer	3.17e-05	0.000401	CbGpPWpGaD
Mercaptopurine—ABCC5—Metabolism—GSTT1—urinary bladder cancer	3.08e-05	0.000389	CbGpPWpGaD
Mercaptopurine—TPMT—Metabolism—MTHFR—urinary bladder cancer	2.98e-05	0.000377	CbGpPWpGaD
Mercaptopurine—ABCC4—Platelet activation, signaling and aggregation—SRC—urinary bladder cancer	2.96e-05	0.000375	CbGpPWpGaD
Mercaptopurine—ABCC5—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	2.88e-05	0.000365	CbGpPWpGaD
Mercaptopurine—AOX1—Metabolism—NQO1—urinary bladder cancer	2.87e-05	0.000363	CbGpPWpGaD
Mercaptopurine—ABCC4—Hemostasis—PLAU—urinary bladder cancer	2.8e-05	0.000354	CbGpPWpGaD
Mercaptopurine—PPAT—Metabolism—PTGS2—urinary bladder cancer	2.7e-05	0.000342	CbGpPWpGaD
Mercaptopurine—HPRT1—Metabolism—PTGS2—urinary bladder cancer	2.7e-05	0.000342	CbGpPWpGaD
Mercaptopurine—XDH—Metabolism—NQO1—urinary bladder cancer	2.67e-05	0.000338	CbGpPWpGaD
Mercaptopurine—AOX1—Disease—NCOR1—urinary bladder cancer	2.62e-05	0.000332	CbGpPWpGaD
Mercaptopurine—ABCC5—Metabolism—NQO1—urinary bladder cancer	2.56e-05	0.000324	CbGpPWpGaD
Mercaptopurine—AOX1—Disease—ERCC2—urinary bladder cancer	2.47e-05	0.000312	CbGpPWpGaD
Mercaptopurine—TPMT—Metabolism—PPARG—urinary bladder cancer	2.42e-05	0.000306	CbGpPWpGaD
Mercaptopurine—AOX1—Metabolism—GSTP1—urinary bladder cancer	2.39e-05	0.000303	CbGpPWpGaD
Mercaptopurine—PPAT—Metabolism—PTEN—urinary bladder cancer	2.35e-05	0.000298	CbGpPWpGaD
Mercaptopurine—HPRT1—Metabolism—PTEN—urinary bladder cancer	2.35e-05	0.000298	CbGpPWpGaD
Mercaptopurine—ABCC5—Disease—NCOR1—urinary bladder cancer	2.34e-05	0.000296	CbGpPWpGaD
Mercaptopurine—TPMT—Metabolism—CREBBP—urinary bladder cancer	2.32e-05	0.000294	CbGpPWpGaD
Mercaptopurine—AOX1—Disease—MTHFR—urinary bladder cancer	2.32e-05	0.000294	CbGpPWpGaD
Mercaptopurine—AOX1—Disease—TERT—urinary bladder cancer	2.31e-05	0.000293	CbGpPWpGaD
Mercaptopurine—ABCC4—Hemostasis—CREBBP—urinary bladder cancer	2.31e-05	0.000292	CbGpPWpGaD
Mercaptopurine—ABCC4—Hemostasis—IGF1—urinary bladder cancer	2.28e-05	0.000288	CbGpPWpGaD
Mercaptopurine—PPAT—Metabolism—EP300—urinary bladder cancer	2.24e-05	0.000284	CbGpPWpGaD
Mercaptopurine—HPRT1—Metabolism—EP300—urinary bladder cancer	2.24e-05	0.000284	CbGpPWpGaD
Mercaptopurine—XDH—Metabolism—GSTP1—urinary bladder cancer	2.22e-05	0.000282	CbGpPWpGaD
Mercaptopurine—AOX1—Metabolism—TYMS—urinary bladder cancer	2.22e-05	0.000282	CbGpPWpGaD
Mercaptopurine—ABCC5—Disease—ERCC2—urinary bladder cancer	2.2e-05	0.000278	CbGpPWpGaD
Mercaptopurine—AOX1—Metabolism—GSTM1—urinary bladder cancer	2.2e-05	0.000278	CbGpPWpGaD
Mercaptopurine—AOX1—Metabolism—NCOR1—urinary bladder cancer	2.2e-05	0.000278	CbGpPWpGaD
Mercaptopurine—ABCC5—Metabolism—GSTP1—urinary bladder cancer	2.13e-05	0.00027	CbGpPWpGaD
Mercaptopurine—AOX1—Disease—FGFR3—urinary bladder cancer	2.12e-05	0.000269	CbGpPWpGaD
Mercaptopurine—AOX1—Metabolism—GPX1—urinary bladder cancer	2.1e-05	0.000267	CbGpPWpGaD
Mercaptopurine—ABCC4—Hemostasis—RHOA—urinary bladder cancer	2.09e-05	0.000264	CbGpPWpGaD
Mercaptopurine—SLC22A8—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	2.08e-05	0.000264	CbGpPWpGaD
Mercaptopurine—ABCC5—Disease—MTHFR—urinary bladder cancer	2.07e-05	0.000262	CbGpPWpGaD
Mercaptopurine—XDH—Metabolism—TYMS—urinary bladder cancer	2.07e-05	0.000262	CbGpPWpGaD
Mercaptopurine—AOX1—Metabolism—ERCC2—urinary bladder cancer	2.07e-05	0.000262	CbGpPWpGaD
Mercaptopurine—ABCC5—Disease—TERT—urinary bladder cancer	2.06e-05	0.000261	CbGpPWpGaD
Mercaptopurine—XDH—Metabolism—NCOR1—urinary bladder cancer	2.04e-05	0.000259	CbGpPWpGaD
Mercaptopurine—XDH—Metabolism—GSTM1—urinary bladder cancer	2.04e-05	0.000259	CbGpPWpGaD
Mercaptopurine—ABCC4—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	2e-05	0.000253	CbGpPWpGaD
Mercaptopurine—ABCC5—Metabolism—TYMS—urinary bladder cancer	1.98e-05	0.000251	CbGpPWpGaD
Mercaptopurine—ABCC5—Metabolism—GSTM1—urinary bladder cancer	1.96e-05	0.000248	CbGpPWpGaD
Mercaptopurine—ABCC5—Metabolism—NCOR1—urinary bladder cancer	1.96e-05	0.000248	CbGpPWpGaD
Mercaptopurine—XDH—Metabolism—GPX1—urinary bladder cancer	1.96e-05	0.000248	CbGpPWpGaD
Mercaptopurine—AOX1—Metabolism—MTHFR—urinary bladder cancer	1.94e-05	0.000246	CbGpPWpGaD
Mercaptopurine—XDH—Metabolism—ERCC2—urinary bladder cancer	1.92e-05	0.000243	CbGpPWpGaD
Mercaptopurine—TPMT—Metabolism—PTGS2—urinary bladder cancer	1.9e-05	0.000241	CbGpPWpGaD
Mercaptopurine—ABCC5—Disease—FGFR3—urinary bladder cancer	1.89e-05	0.00024	CbGpPWpGaD
Mercaptopurine—ABCC5—Metabolism—GPX1—urinary bladder cancer	1.88e-05	0.000238	CbGpPWpGaD
Mercaptopurine—ABCC5—Metabolism—ERCC2—urinary bladder cancer	1.84e-05	0.000233	CbGpPWpGaD
Mercaptopurine—AOX1—Disease—CREBBP—urinary bladder cancer	1.81e-05	0.000229	CbGpPWpGaD
Mercaptopurine—XDH—Metabolism—MTHFR—urinary bladder cancer	1.81e-05	0.000229	CbGpPWpGaD
Mercaptopurine—ABCC4—Hemostasis—IL2—urinary bladder cancer	1.75e-05	0.000222	CbGpPWpGaD
Mercaptopurine—ABCC5—Metabolism—MTHFR—urinary bladder cancer	1.73e-05	0.000219	CbGpPWpGaD
Mercaptopurine—TPMT—Metabolism—PTEN—urinary bladder cancer	1.66e-05	0.00021	CbGpPWpGaD
Mercaptopurine—AOX1—Disease—RHOA—urinary bladder cancer	1.63e-05	0.000207	CbGpPWpGaD
Mercaptopurine—ABCC5—Disease—CREBBP—urinary bladder cancer	1.61e-05	0.000204	CbGpPWpGaD
Mercaptopurine—TPMT—Metabolism—EP300—urinary bladder cancer	1.58e-05	0.0002	CbGpPWpGaD
Mercaptopurine—AOX1—Metabolism—PPARG—urinary bladder cancer	1.58e-05	0.000199	CbGpPWpGaD
Mercaptopurine—ABCC4—Hemostasis—EP300—urinary bladder cancer	1.57e-05	0.000199	CbGpPWpGaD
Mercaptopurine—ABCC4—Hemostasis—SRC—urinary bladder cancer	1.53e-05	0.000193	CbGpPWpGaD
Mercaptopurine—AOX1—Metabolism—CREBBP—urinary bladder cancer	1.51e-05	0.000192	CbGpPWpGaD
Mercaptopurine—AOX1—Disease—ERBB2—urinary bladder cancer	1.51e-05	0.000192	CbGpPWpGaD
Mercaptopurine—AOX1—Disease—PTGS2—urinary bladder cancer	1.48e-05	0.000187	CbGpPWpGaD
Mercaptopurine—XDH—Metabolism—PPARG—urinary bladder cancer	1.46e-05	0.000185	CbGpPWpGaD
Mercaptopurine—ABCC5—Disease—RHOA—urinary bladder cancer	1.46e-05	0.000184	CbGpPWpGaD
Mercaptopurine—XDH—Metabolism—CREBBP—urinary bladder cancer	1.41e-05	0.000178	CbGpPWpGaD
Mercaptopurine—ABCC5—Metabolism—PPARG—urinary bladder cancer	1.4e-05	0.000178	CbGpPWpGaD
Mercaptopurine—ABCC5—Metabolism—CREBBP—urinary bladder cancer	1.35e-05	0.000171	CbGpPWpGaD
Mercaptopurine—ABCC5—Disease—ERBB2—urinary bladder cancer	1.35e-05	0.000171	CbGpPWpGaD
Mercaptopurine—ABCC5—Disease—PTGS2—urinary bladder cancer	1.32e-05	0.000167	CbGpPWpGaD
Mercaptopurine—AOX1—Disease—CDKN1A—urinary bladder cancer	1.29e-05	0.000164	CbGpPWpGaD
Mercaptopurine—AOX1—Disease—PTEN—urinary bladder cancer	1.29e-05	0.000163	CbGpPWpGaD
Mercaptopurine—ABCC4—Hemostasis—KRAS—urinary bladder cancer	1.26e-05	0.00016	CbGpPWpGaD
Mercaptopurine—AOX1—Metabolism—PTGS2—urinary bladder cancer	1.24e-05	0.000157	CbGpPWpGaD
Mercaptopurine—AOX1—Disease—EP300—urinary bladder cancer	1.23e-05	0.000156	CbGpPWpGaD
Mercaptopurine—AOX1—Disease—SRC—urinary bladder cancer	1.2e-05	0.000152	CbGpPWpGaD
Mercaptopurine—ABCC5—Disease—CDKN1A—urinary bladder cancer	1.15e-05	0.000146	CbGpPWpGaD
Mercaptopurine—XDH—Metabolism—PTGS2—urinary bladder cancer	1.15e-05	0.000146	CbGpPWpGaD
Mercaptopurine—ABCC5—Disease—PTEN—urinary bladder cancer	1.15e-05	0.000146	CbGpPWpGaD
Mercaptopurine—ABCC4—Hemostasis—TP53—urinary bladder cancer	1.12e-05	0.000142	CbGpPWpGaD
Mercaptopurine—ABCC5—Metabolism—PTGS2—urinary bladder cancer	1.1e-05	0.00014	CbGpPWpGaD
Mercaptopurine—ABCC5—Disease—EP300—urinary bladder cancer	1.1e-05	0.000139	CbGpPWpGaD
Mercaptopurine—AOX1—Metabolism—PTEN—urinary bladder cancer	1.08e-05	0.000137	CbGpPWpGaD
Mercaptopurine—ABCC4—Hemostasis—HRAS—urinary bladder cancer	1.07e-05	0.000136	CbGpPWpGaD
Mercaptopurine—AOX1—Disease—MYC—urinary bladder cancer	1.07e-05	0.000136	CbGpPWpGaD
Mercaptopurine—ABCC5—Disease—SRC—urinary bladder cancer	1.07e-05	0.000135	CbGpPWpGaD
Mercaptopurine—AOX1—Disease—EGFR—urinary bladder cancer	1.05e-05	0.000133	CbGpPWpGaD
Mercaptopurine—AOX1—Metabolism—EP300—urinary bladder cancer	1.03e-05	0.00013	CbGpPWpGaD
Mercaptopurine—XDH—Metabolism—PTEN—urinary bladder cancer	1e-05	0.000127	CbGpPWpGaD
Mercaptopurine—AOX1—Disease—KRAS—urinary bladder cancer	9.91e-06	0.000125	CbGpPWpGaD
Mercaptopurine—ABCC5—Metabolism—PTEN—urinary bladder cancer	9.63e-06	0.000122	CbGpPWpGaD
Mercaptopurine—XDH—Metabolism—EP300—urinary bladder cancer	9.58e-06	0.000121	CbGpPWpGaD
Mercaptopurine—ABCC5—Disease—MYC—urinary bladder cancer	9.56e-06	0.000121	CbGpPWpGaD
Mercaptopurine—ABCC5—Disease—EGFR—urinary bladder cancer	9.35e-06	0.000118	CbGpPWpGaD
Mercaptopurine—ABCC5—Metabolism—EP300—urinary bladder cancer	9.18e-06	0.000116	CbGpPWpGaD
Mercaptopurine—ABCC5—Disease—KRAS—urinary bladder cancer	8.83e-06	0.000112	CbGpPWpGaD
Mercaptopurine—AOX1—Disease—HRAS—urinary bladder cancer	8.42e-06	0.000107	CbGpPWpGaD
Mercaptopurine—ABCC5—Disease—HRAS—urinary bladder cancer	7.51e-06	9.5e-05	CbGpPWpGaD
